Prognostic Factors of 30-Day Mortality After Palliative Procedures in Patients with Malignant Pleural Effusion
Related Experiment Videos
Fernando Conrado Abrao1, Igor Renato Louro Bruno de Abreu2, Mariana Fogarolli2
1Department of Thoracic Surgery, Hospital São José, São Paulo, SP, Brazil. fernandocabrao@uol.com.br.
Background:
The aim of this study was to identify predictors of 30-day mortality in patients with malignant pleural effusion (MPE) who need pleural palliative procedures.
Methods:
Data was prospectively collected from our database, between January 2013 and July 2014 on 86 patients with MPE and complete follow-up 30 days after the procedure. The sample was divided into two groups. The first group (G1) included patients who had died up to 30 days after the palliative procedure, and the second group (G2) included patients who survived for more than 30 days after the palliative procedure. The identification of prognostic factors occurred through univariate analysis using Fisher exact test for analysis of categorical variables and the t test for quantitative variables. Subsequently, all variables were used in the multivariate logistic regression analysis. The cutoff values for any significant continuous variables were determined by receiver operating characteristics analysis.
Results:
There were 24 patients in G1 and 62 patients in G2. Univariate analysis of factors affecting postprocedural survival disclosed nine factors that were associated with significantly reduced postoperative survival. At the multivariate analysis, high levels of white blood cells, (p = .013), low levels of red blood cells (p < .0001) and protein in pleural fluid (p = .001), and primary lung and gastrointestinal sites (p = .0076) were identified as independent predictors of mortality.
Conclusions:
We identified four factors that are easily recognized in daily practice and can help select patients with low life expectancy. Therefore, invasive procedures and hospitalizations for this subgroup of patients can be prevented.
Insights
Predictors of 30-day mortality in malignant pleural effusion (MPE) patients undergoing palliative procedures include high white blood cell counts, low red blood cell counts, low pleural fluid protein, and primary lung or gastrointestinal cancer sites.
Area of Science:
- Oncology
- Pulmonology
- Palliative Care
Background:
- Malignant pleural effusion (MPE) poses a significant challenge in palliative care.
- Identifying predictors of mortality is crucial for optimizing patient management and resource allocation.
Purpose of the Study:
- To identify predictors of 30-day mortality in patients with MPE undergoing pleural palliative procedures.
- To aid in selecting patients who may not benefit from aggressive interventions.
Main Methods:
- Prospective data collection from January 2013 to July 2014 on 86 MPE patients.
- Division into two groups: 30-day mortality (G1) and survival (G2).
- Univariate and multivariate logistic regression analyses, including Fisher exact test, t-test, and ROC analysis.
Main Results:
- Multivariate analysis identified independent predictors of mortality.
- High white blood cell count (p = .013) and low red blood cell count (p < .0001) were significant.
- Low pleural fluid protein (p = .001) and primary lung/gastrointestinal sites (p = .0076) also predicted mortality.
Conclusions:
- Four easily recognizable factors predict 30-day mortality in MPE patients.
- These predictors can help prevent unnecessary invasive procedures and hospitalizations for high-risk patients.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
Pneumothorax-II
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pulmonary Embolism III: Nursing Management
Pneumonia III: Complications and Assessment